ArticlePloS one2025

Evaluating elexacaftor/tezacaftor/ivacaftor (ETI; Trikafta™) for treatment of patients with non-cystic fibrosis bronchiectasis (NCFBE): A clinical study protocol.

Colin E Swenson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.